As of 30.01.2020
Name of the project: Proteomics. Molecular pharmacology. Medical chemistry.
Strategy for Scientific and Technological Development Priority Level: в
Research directions: Development of new pharmaceutical agents for treatent of oncological diseases and conditions caused by the metabolic syndrome.
Project objective: Research of possibility of creation of new pharmaceutical agents based on reactivation of functions of tumor suppressor agents of the p53 family and inducting autophagy.
Hosting organization
|
Field of studies
|
City
|
Invited researcher
|
Time span of the project
|
---|---|---|---|---|
Laboratory of Super-elastic Bio-interfaces
National Research Tomsk State University |
Medical biotechnologies |
Tomsk |
Volinsky Alexei
USA |
2021-2023 |
Laboratory of Clinical Smart Nano-technologies
I.M.Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenovskiy University) |
Medical biotechnologies |
Moscow |
Liang Xing-Ji
China |
2021-2023 |
Laboratory of Laser Molecular Imaging and Machine Learning
National Research Tomsk State University |
Medical biotechnologies |
Tomsk |
Igor Konstantinovich Lednev
Russia |
2021-2023 |